Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. September 2020 08:00 ET | Quelle: Bionano Genomics

Bionano to Present at the September 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Erik Holmlin, Ph.D., CEO of Bionano, will present a company overview and be available for...
17. September 2020 08:00 ET | Quelle: Bionano Genomics

Bionano Data Provides Understanding of Repeat Expansion Disorders Causing Muscular Dystrophy and ALS

SAN DIEGO, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that teams from the Mayo Clinic and from the University of Florida have separately released...
16. September 2020 08:00 ET | Quelle: Bionano Genomics

Bionano Genomics Continues to See Expansion in the Adoption of Saphyr for Digital Cytogenetics at Leading Medical Institutions

SAN DIEGO, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that its Saphyr system has been adopted through reagent-rentals by four additional institutions in...
14. September 2020 08:00 ET | Quelle: Bionano Genomics

Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy

EpiPanelDx PLUS adds to Lineagen’s expanding menu of diagnostic tests for children with developmental disorders and provides an offering designed specifically for patients that have experienced...
10. September 2020 08:00 ET | Quelle: Bionano Genomics

Bionano Genomics Announces Continued Expansion of European Business With Adoption of Saphyr at Three of Europe’s Largest Pediatric Hospitals in Spain, Italy and France

SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that its Saphyr system has been adopted through reagent-rental agreements by three renowned...
09. September 2020 08:00 ET | Quelle: Bionano Genomics

Vertebrate Genome Project Rules Bionano Optical Mapping Technology As Essential Part of Assembling Reference Quality Genomes

SAN DIEGO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that the International Genome 10K (G10K) Consortium selected Bionano optical mapping technology as...
04. September 2020 18:00 ET | Quelle: Bionano Genomics

Bionano Genomics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Sept. 04, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that, in accordance with Nasdaq Listing Rule 5635(c)(4), the Compensation Committee of its Board...
03. September 2020 08:00 ET | Quelle: Bionano Genomics

Independent Proxy Advisory Firm ISS Recommends Bionano Stockholders Vote “FOR” Authorized Shares Increase Proposal

SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Institutional Shareholder Services (ISS), a leading independent proxy advisory firm, has...
02. September 2020 08:00 ET | Quelle: Bionano Genomics

Bionano Genomics Data is a Key to Understanding Cancer Genome Structures That Make Tumors Grow Aggressively

SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today a study published in the journal Nature Communications used its genome imaging technology to...
31. August 2020 17:59 ET | Quelle: Bionano Genomics

Bionano Genomics Announces Adjournment of Special Meeting of Stockholders to September 29, 2020

SAN DIEGO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it has adjourned its Special Meeting of Stockholders held on August 31, 2020 to allow...

Vorherige Seite